![Calcitonin as a Tumor Marker — Use of the Radioimmunoassay for Calcitonin in the Postoperative Evaluation of Patients with Medullary Thyroid Carcinoma | NEJM Calcitonin as a Tumor Marker — Use of the Radioimmunoassay for Calcitonin in the Postoperative Evaluation of Patients with Medullary Thyroid Carcinoma | NEJM](https://www.nejm.org/na101/home/literatum/publisher/mms/journals/content/nejm/1974/nejm_1974.290.issue-19/nejm197405092901901/20130816/images/img_medium/nejm197405092901901_t1.jpeg)
Calcitonin as a Tumor Marker — Use of the Radioimmunoassay for Calcitonin in the Postoperative Evaluation of Patients with Medullary Thyroid Carcinoma | NEJM
Thyroid Cancer Tumor Marker Calcitonin Stock Photo - Download Image Now - Abstract, Bar Code, Blood - iStock
![PDF] Calcitonin – a hormone seeking a job Calcitonin precursors : the markers of sepsis ? | Semantic Scholar PDF] Calcitonin – a hormone seeking a job Calcitonin precursors : the markers of sepsis ? | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/87c372660d0a2e38f9cd6bce133e59b72ab9c554/2-Figure1-1.png)
PDF] Calcitonin – a hormone seeking a job Calcitonin precursors : the markers of sepsis ? | Semantic Scholar
![Calcitonin as a Tumor Marker — Use of the Radioimmunoassay for Calcitonin in the Postoperative Evaluation of Patients with Medullary Thyroid Carcinoma | NEJM Calcitonin as a Tumor Marker — Use of the Radioimmunoassay for Calcitonin in the Postoperative Evaluation of Patients with Medullary Thyroid Carcinoma | NEJM](https://www.nejm.org/na101/home/literatum/publisher/mms/journals/content/nejm/1974/nejm_1974.290.issue-19/nejm197405092901901/20130816/images/img_small/nejm197405092901901_f2.jpeg)
Calcitonin as a Tumor Marker — Use of the Radioimmunoassay for Calcitonin in the Postoperative Evaluation of Patients with Medullary Thyroid Carcinoma | NEJM
![ENDOCRINE TUMOURS: Calcitonin in thyroid and extra-thyroid neuroendocrine neoplasms: the two-faced Janus in: European Journal of Endocrinology Volume 183 Issue 6 (2020) ENDOCRINE TUMOURS: Calcitonin in thyroid and extra-thyroid neuroendocrine neoplasms: the two-faced Janus in: European Journal of Endocrinology Volume 183 Issue 6 (2020)](https://eje.bioscientifica.com/view/journals/eje/183/6/images/EJE-20-0506fig2.jpeg)
ENDOCRINE TUMOURS: Calcitonin in thyroid and extra-thyroid neuroendocrine neoplasms: the two-faced Janus in: European Journal of Endocrinology Volume 183 Issue 6 (2020)
![Frontiers | Prognostic Value of Preoperative Serum Calcitonin Levels for Predicting the Recurrence of Medullary Thyroid Carcinoma Frontiers | Prognostic Value of Preoperative Serum Calcitonin Levels for Predicting the Recurrence of Medullary Thyroid Carcinoma](https://www.frontiersin.org/files/MyHome%20Article%20Library/749973/749973_Thumb_400.jpg)
Frontiers | Prognostic Value of Preoperative Serum Calcitonin Levels for Predicting the Recurrence of Medullary Thyroid Carcinoma
![SciELO - Brasil - Hypercalcitoninemia is not pathognomonic of medullary thyroid carcinoma Hypercalcitoninemia is not pathognomonic of medullary thyroid carcinoma SciELO - Brasil - Hypercalcitoninemia is not pathognomonic of medullary thyroid carcinoma Hypercalcitoninemia is not pathognomonic of medullary thyroid carcinoma](https://minio.scielo.br/documentstore/1980-5322/3R5NJTvSjD9SCNcY5CdkWpN/d667d43f01beb7557cdafbb931cc600bc2193e4f.gif)
SciELO - Brasil - Hypercalcitoninemia is not pathognomonic of medullary thyroid carcinoma Hypercalcitoninemia is not pathognomonic of medullary thyroid carcinoma
![Frontiers | Serum Calcitonin-Negative Medullary Thyroid Carcinoma: A Case Series of 19 Patients in a Single Center Frontiers | Serum Calcitonin-Negative Medullary Thyroid Carcinoma: A Case Series of 19 Patients in a Single Center](https://www.frontiersin.org/files/Articles/747704/fendo-12-747704-HTML/image_m/fendo-12-747704-g001.jpg)
Frontiers | Serum Calcitonin-Negative Medullary Thyroid Carcinoma: A Case Series of 19 Patients in a Single Center
![Tumor marker and measurement fluctuations may not reflect treatment efficacy in patients with medullary thyroid carcinoma on long-term RET inhibitor therapy - Annals of Oncology Tumor marker and measurement fluctuations may not reflect treatment efficacy in patients with medullary thyroid carcinoma on long-term RET inhibitor therapy - Annals of Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/904c6f44-d754-42b3-8e58-749bedfcd245/gr1_lrg.jpg)
Tumor marker and measurement fluctuations may not reflect treatment efficacy in patients with medullary thyroid carcinoma on long-term RET inhibitor therapy - Annals of Oncology
![Carcinoembryonic antigen should be concurrently checked with calcitonin to identify distant metastases in medullary thyroid cancer | International Journal of Endocrine Oncology Carcinoembryonic antigen should be concurrently checked with calcitonin to identify distant metastases in medullary thyroid cancer | International Journal of Endocrine Oncology](https://www.futuremedicine.com/cms/10.2217/ije-2019-0016/asset/images/medium/figure2.gif)